Marshall Lerner delivered a presentation to a group of undergraduate, doctoral and postdoctoral students in the Chemistry Department of Harvard University on April 16, 2018 about the CRISPR patent litigation and the use of CRISPR in eukaryotic cells. A CRISPR-Cas9 system is a combination of protein and ribonucleic acid (“RNA”) that can alter the genetic sequence of an organism. In their natural environment, CRISPR-Cas systems protect bacteria against infection by viruses. The CRISPR-Cas9 system is […]

Read More